With over a century of collective experience, the team at AARDEX Group is expertly equipped to revolutionize the measurement of medication adherence in clinical trials. Our team comprises industry experts dedicated to advancing the field of medication adherence through cutting-edge technologies and innovative approaches. They are passionate about improving patient outcomes and strive to develop solutions tailored to meet each study's unique needs. Our team's tireless efforts are driven by a commitment to excellence and innovation, ensuring we continue to set the gold standard for medication adherence measurement in clinical trials. We are proud to have such a dedicated and experienced team working to support our clients.
Find out more about Aardex Group’s MEMs Software
As CEO and Scientific Lead, his expertise and ingenuity are indispensable to the success of the company. A distinguished graduate from Ghent University, Belgium, with a PhD in Applied Mathematics and Informatics, Dr. Vrijens has pioneered a research program focused on a simple but robust taxonomy of common dosing errors, along with exploring optimal measurement-guided medication management that can drive adherence and maintain long-term persistence. With over 100 peer-reviewed scientific papers and six patents to his name, Dr. Vrijens is also a founding member of the International Society for Medication Adherence (ESPACOMP) and an active contributor to several EU and US-funded collaborative projects, cementing his status as a leading authority in the field.
As R&D Department Manager and Software Lead at AARDEX Group, Benjamin leads the development of innovative software solutions that support better medication adherence and empower individuals in their health journey. With a strong focus on software and cloud architecture, he guides a multidisciplinary team in building reliable, scalable, and user-centric systems that meet the highest standards of quality. « At the heart of my leadership is a commitment to creating a collaborative and supportive environment, where each team member is encouraged to grow, contribute, and thrive. I believe that technical excellence and human development go hand in hand, and that the best solutions emerge when innovation is nurtured by trust, curiosity, and shared purpose. Driven by a passion for meaningful technology, I am dedicated to delivering solutions that make a real difference for our users, our clients, and the future of healthcare», says Benjamin.
Meet Eric Tousset – the Operational Lead at AARDEX Group, driving cutting-edge adherence monitoring systems for drug development and medical practice development and implementation. With his keen eye for detail and unparalleled technical prowess, Eric is an integral part of the team responsible for revolutionizing medication adherence. But his expertise doesn’t stop there – Eric is also a master of modeling the rich data collected by these systems, unlocking valuable insights that have the potential to transform the landscape of healthcare as we know it. With his passion for innovation and unwavering commitment to excellence, Eric Tousset is a force to be reckoned with in the world of medication adherence.
As a seasoned software developer, Jean-Michel’s journey has involved diverse business sectors. In the 90s, he stumbled upon a game-changing innovation- smart packages for medication management. Riding the wave of this nascent technology, Jean-Michel collaborated with industry pioneers to craft innovative software solutions that addressed the pervasive issue of adherence. His visionary approach to constructing our datacenter paved the way for a more holistic approach, and as Quality Manager, he was involved in the pursuit of excellence. Today, as Product officer, Jean-Michel leverages his prowess in software development, IT, and quality to create unparalleled solutions for customers, aiding them in unlocking the full potential of their treatments.
WEBINAR WITH MERCK & BIOGEN
Mitigating the Risk of Poor Adherence in Trials
Watch this live recording with adherence experts from Merck & Biogen to learn about their approach to mitigating the risk of poor adherence in trials.
FROM THE AARDEX GROUP BLOG
We are thrilled to feature expert insights from Bernard Vrijens, a world-renowned expert on medication adherence. Taking medication as prescribed is crucial to achieving optimal health outcomes, yet non-adherence is a prevalent issue. Bernard Vrijens' extensive research and experience in the field provide invaluable insights into the factors that contribute to medication non-adherence and effective strategies to address them. His contributions to our medication adherence blog offer actionable advice and evidence-based recommendations to improve medication adherence and ultimately, patient outcomes.
What Is Patient Adherence and Why It Matters According to the World Health Organization (WHO), “adherence to long-term therapies is the extent to which a person’s behavior, taking medication, following a diet, and executing lifestyle changes corresponds with agreed recommendations
As humans, the unconscious act of making assumptions is inherent in our DNA. These mental shortcuts are deep wired into our brains as a way of quickly making sense of the world around us. And yet, throughout history, great thinkers
The perfectionists among us might outwardly disagree, but, in truth, even they would secretly admit that it is not possible to live a life free from mistakes. We are complex beings living and working in complex environments and, therefore, we
Clinical trials rely on accurate data. But what if one of the most important variables whether a patient actually takes the medication is based on guesswork? Traditional methods like pill counts, diaries, or verbal confirmation have long been the standard,
Imagine spending years developing a promising new treatment, only to have its potential clouded by something as simple (and as overlooked) as whether or not people actually took their pills. This isn’t just a small glitch in the process. In
You’ll often hear the terms “adherence” and “compliance” used as if they mean the same thing. But in healthcare and clinical research, they carry very different meanings. Understanding that difference can change the way we work with patients, design better